Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
Key PointsThe Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF.
The Invesco Pharmaceuticals ETF (PJP) and Invesco S&P 500 Equal Weight Health Care ETF (RSPH) are two Invesco funds that investors compare when seeking exposure to the healthcare industry. PJP concentrates on pharmaceutical companies with lower historical volatility, whereas RSPH offers a more diversified approach by equal-weighting every healthcare constituent within the S&P 500, encompassing medical devices and services firms.
Investors must consider beta, which measures price volatility relative to the S&P 500. Calculated from monthly returns over the available fund history (up to five years), beta provides insight into the funds' price sensitivity.
Looking at the 1-year return, which represents total return over the trailing 12 months, reveals the funds' performance during this period. The dividend yield, measured as the trailing-12-month distribution yield, adds another layer of consideration for investors seeking income from their investments.
In summary, PJP targets pharmaceuticals with a focus on lower volatility, while RSPH takes a broader sector approach by equal-weighting all healthcare companies in the S&P 500. Investors must weigh these differences to determine which fund aligns best with their investment objectives.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
